Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India

"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these unmet gaps comes from our patient-first approach," Zydus Cadila MD Sharvil Patel told .

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WyzRvw
via IFTTT